Global Kyphosis Market: The Current Scenario

Overview of Kyphosis 

Kyphosis is a spinal disorder with an abnormal curve of the upper spine and back, resulting in a ‘hunchback’ condition. By straightening the spine, most patients show no symptoms, although some patients may experience back pain, tenderness of the spine and fatigue. If chronic kyphosis is not treated, it may result in chronic pain and poorly managed breathing, so the importance of treatment and timely diagnosis cannot be overemphasized.

Current Market Landscape 

The global kyphosis market is growing steadily, driven by: 

• Increased cases of spine disorders like brittle bone disease (Osteoporosis) that lead to kyphosis. 
• Increased healthcare spending and patients are better informed about their spinal health. 
• Increased availability of advanced diagnostics and treatment due to increased R&D.

Despite these market drivers, the limited availability of treatment options, and apathetic patients and caregivers, results in market stagnation. 

Regional Insights 

The global kyphosis market is segmented into the Asia-Pacific region, the Americas, Europe, and the Middle East and Africa. In 2018, Europe had the largest market share, with most of it residing in Western Europe, particularly the UK, Germany, France, Spain and Italy. 

North America is another important market, with the region increasing spending on healthcare and patients being more informed about their health.

When it comes to growth potential, the Asia-Pacific region looks promising, especially in Japan, China, India, South Korea, and Australia. 

Conclusions 

One of the main reasons for the gradual growth of the global market for kyphosis is the increasing occurrence of the condition, new technology for diagnosis and treatment, and rising health expenditure. The market is expected to grow considerably, especially with the innovative market therapies, due to the awareness of innovative therapies and will create potential for healthcare providers, medical device manufacturers, and investors.